GENAIRX
LIVE

Serial Number

50016360

Owner

Genairx Inc.

Attorney

Joel R. Feldman

Filing Date

Jul 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GENAIRX Trademark

Serial Number: 50016360

GENAIRX is a trademark filed by Genairx Inc. on July 27, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Genairx Inc. (3 trademarks)

160B Cedric Ave.
York, ON M6C3X8 , CA

Entity Type: 03

Trademark Details

Filing Date

July 27, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; Pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely anti-inflammatory analgesics; pharmaceutical preparations, namely, pharmaceutical preparations for treating high cholesterol, pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for the treatment of diabetes, cancer; diagnostic reagents for scientific or medical research use; scientific and medical compounds, namely, protein kinases and phosphatases; Pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of cancerous tumors; Pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses, namely osteoarthritis, rheumatoid arthritis, lupus, ankylosing spondylitis, Sjogren's syndrome, gout, fibromyalgia, and polymyalgia rheumatica; general anesthetics, analgesics, frostbite salve for pharmaceutical purposes, hemorrhoid preparations, pharmaceutical preparations for the treatment of headaches, salts for medicated baths, mouthwashes for medical purposes, tranquillizers, sedatives, tobacco free cigarettes for smoking cessation treatments, medicines for alleviating constipation, contraceptives chemicals, radiological contrast substances for medical purposes, diagnostic preparations for medical purposes, namely lubricants and gels for ultrasound and gynecological diagnostic procedures; drugs for the treatment of pain, fever, angina otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, and rheumatic illnesses, namely osteoarthritis, rheumatoid arthritis, lupus, ankylosing spondylitis, Sjogren's syndrome, gout, fibromyalgia, and polymyalgia rheumatica; mineral water; Pharmaceutical preparations for the treatment of smooth muscle disorders, namely stroke, Parkinson's disease, multiple sclerosis, Huntington's disease, Creutzfeldt Jakob disease, Amyotrophic lateral sclerosis, muscular dystrophy, inflammatory myopathies, and dystonias, headaches, wrinkles, hyperhidrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, bladder pain; pharmaceutical preparations for the treatment of cerebral palsy; Pharmaceutical preparations and substances, namely anti-infectives, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, cardiovascular preparations, hemostatic agents, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; Prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, peripheral nervous system, namely diabetic nerve problems, Guillaume-Barr syndrome, carpal tunnel syndrome, thoracic outlet syndrome, complex regional pain and brachial plexus injuries, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for treatment of chronic pain, general anesthetics; pharmaceutical preparations and substances for use in oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; Pharmaceutical preparation and substances, namely hematinics which increase the hemoglobin content of the blood

Non-downloadable artificial intelligence software for pharmaceutical research and development; conducting research, development and evaluations in the field of pharmaceutical formulations

Downloadable artificial intelligence software for pharmaceutical research and development; conducting research, development and evaluations in the field of pharmaceutical formulations.

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 27, 2026 MAFR
NEW APPLICATION ENTERED
Jul 27, 2026 NWAP